{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:53Z","timestamp":1787070833384,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Glottic cancer has an excellent probability of cure. The early glottic cancer is usually treated by radiotherapy with different fractionation schedules. The aim of this study was to compare conventional versus hypofractionated radiotherapy with respect to overall survival and disease-free survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of fifty patients with T1-2N0M0 glottic cancer with no previous treatment history were prospectively randomized into two arms. In Arm A (Study), patients received a total of 55 Gy in 20# at 2.75 Gy\/#, 5 days a week. In Arm B (Control), patients received a total of 66 Gy in 33# at 2 Gy\/#, 5 days a week. Disease response was evaluated by the WHO criteria at the end of treatment, then at 1, 2, and 3 months to complete their 6-month follow-up. Overall survival and disease-free survival were evaluated at 1, 2, and 3 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Overall, 100% of patients in the study arm and 96% of patients in the control arm had complete response after 6 months. Overall survival rates at 1, 2, and 3 years were 96%, 96%, and 88%, respectively, in the study arm, while in the control arm, these values were 92%, 84%, and 80%, respectively, and the difference was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Disease-free survival at 3 years was 88% in the study arm and 80% in the control arm.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study suggests that hypofractionated regimen may be better in local control and symptomatic relief with the added advantage of shorter treatment time, which offers better patient compliance and advantageous in busy setups where there is heavy patient load.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_867_19","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T07:43:37Z","timestamp":1622187817000},"page":"1499-1502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0"],"prefix":"10.4103","volume":"17","author":[{"given":"Avni","family":"Kachhwaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Lal","family":"Jakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Syiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder Singh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-31-20241021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/oxfordjournals.epirev.a036223","article-title":"Epidemiology of laryngeal cancer","volume":"2","author":"Rothman","year":"1980","journal-title":"Epidemiol Rev"},{"key":"R3-31-20241021","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2273.1991.tb01976.x","article-title":"The incidence of cancer of the larynx","volume":"16","author":"Robin","year":"1991","journal-title":"Clin Otolaryngol"},{"key":"R4-31-20241021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R5-31-20241021","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/cncr.20181","article-title":"Management of T1-T2 glottic carcinomas","volume":"100","author":"Mendenhall","year":"2004","journal-title":"Cancer"},{"key":"R6-31-20241021","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/02841860152703409","article-title":"Treatment outcome after laser excision of early glottic squamous cell carcinoma--a literature survey","volume":"40","author":"Luscher","year":"2001","journal-title":"Acta Oncol"},{"key":"R7-31-20241021","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0194-5998(99)70051-3","article-title":"Voice quality after narrow-margin laser cordectomy compared with laryngeal irradiation","volume":"121","author":"Delsupehe","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R8-31-20241021","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijrobp.2007.05.036","article-title":"Multidisciplinary management of laryngeal carcinoma","volume":"69","author":"Mendenhall","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-31-20241021","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1200\/JCO.2001.19.20.4029","article-title":"T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy","volume":"19","author":"Mendenhall","year":"2001","journal-title":"J Clin Oncol"},{"key":"R10-31-20241021","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-31-20241021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0360-3016(97)00284-8","article-title":"Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma","volume":"39","author":"Le","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-31-20241021","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-31-20241021","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clon.2009.02.008","article-title":"Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: The Birmingham experience","volume":"21","author":"Cheah","year":"2009","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"R14-31-20241021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0167-8140(03)00059-8","article-title":"Three weeks radiotherapy for T1 glottic cancer: The Christie and Royal Marsden Hospital experience","volume":"68","author":"Gowda","year":"2003","journal-title":"Radiother Oncol"},{"key":"R15-31-20241021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiology.182.1.1727295","article-title":"Early stage glottis cancer: Importance of dose fractionation in radiation therapy","volume":"182","author":"Kim","year":"1992","journal-title":"Radiology"},{"key":"R16-31-20241021","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archotol.1991.01870190086018","article-title":"Gender influences subsite or origin of laryngeal carcinoma","volume":"117","author":"Stephenson","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R17-31-20241021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM199301213280302","article-title":"Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer","volume":"328","author":"Browman","year":"1993","journal-title":"N Engl J Med"},{"key":"R19-31-20241021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1748-717X-7-193","article-title":"Definitive radiotherapy for early (T1-T2) glottis squamous cell carcinoma: A 20 year Cleveland clinic experience","volume":"7","author":"Khan","year":"2012","journal-title":"Radiat Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_867_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:22Z","timestamp":1787067442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_867_19"}},"subtitle":["A randomized study"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_867_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}